Filter
5056
Text search:
Drug
research
Featured
Recommendations
431
New Publications
1265
Language
Document type
No document type
2964
Studies & Reports
889
Guidelines
629
Manuals
212
Strategic & Response Plan
162
Fact sheets
79
Training Material
60
Situation Updates
17
Infographics
12
Brochures
11
Resource Platforms
11
Online Courses
3
App
2
Videos
2
Countries / Regions
India
274
Global
182
Kenya
157
South Africa
113
Western and Central Europe
110
Uganda
109
Ethiopia
108
Nigeria
105
Nepal
89
Tanzania
84
Africa
84
Zambia
79
Malawi
78
Liberia
77
Sierra Leone
73
Latin America and the Carribbean
69
Ghana
67
Myanmar / Burma
67
Bangladesh
63
Ukraine
56
Eastern Europe
56
Rwanda
53
Namibia
44
Asia
44
Philippines
43
Russia
42
Zimbabwe
39
Cambodia
36
Lesotho
32
South–East Asia Region
32
Indonesia
30
Mozambique
25
Congo, Democratic Republic of
23
Brazil
23
Botswana
23
Senegal
20
Syria
20
Germany
18
Burkina Faso
17
Eswatini/ Swaziland
17
East and Southern Africa
17
South Sudan
16
Colombia
16
Cameroon
14
West and Central Africa
14
Tajikistan
14
USA
13
Haiti
13
Thailand
13
Middle East and North Africa
13
Pakistan
11
China
11
Eastern Europe and Central Asia
11
Vietnam
11
Sudan
10
Argentina
10
Albania
10
Georgia
10
Guinea
9
Afghanistan
8
Venezuela
8
Laos
8
North Macedonia
7
Benin
6
Sri Lanka
6
Armenia
6
Moldova
6
Iraq
5
Mexico
5
Yemen
5
Western Pacific Region
5
Jordan
4
Lebanon
4
Central African Republic
4
Peru
4
Angola
4
Timor Leste/ East Timor
4
Iran
4
United Kingdom
4
Guinea-Bissau
3
Somalia
3
Turkey
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Libya
3
Chile
3
Paraguay
3
Bhutan
3
Kyrgyzstan
3
North America
3
Jamaica
3
Belarus
3
Mali
2
Morocco
2
Saudi Arabia
2
Hungary
2
Honduras
2
Ecuador
2
Poland
2
Palestine
2
Southern Africa
2
Canada
2
Estonia
2
Kazakhstan
2
Belgium
2
Portugal
2
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Chad
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Bolivia
1
Greece
1
Guatemala
1
Nicaragua
1
Fiji
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Romania
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1853
Clinical Guidelines
427
Public Health
240
Women & Child Health
179
Key Resources
124
Pharmacy & Technologies
66
Capacity Building
64
Annual Report MEDBOX
1
Toolboxes
HIV
621
Mental Health
569
TB
505
AMR
267
NTDs
236
COVID-19
210
Pharmacy
125
NCDs
106
Malaria
99
Caregiver
87
Ebola & Marburg
80
Planetary Health
74
Rapid Response
56
Disability
55
Refugee
54
Global Health Education
53
Conflict
44
Health Financing Toolbox
43
2.0 Rapid Response
23
Polio
20
Natural Hazards
16
Zika
16
Specific Hazards
15
Social Ethics
13
Cholera
11
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha
...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property fo
...
This report outlines the Ministry of Health’s National Health Research Agenda in which it identifies research priorities in health. It will be implemented in the same time frame as the Health Sect
...
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have lea
...
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P
...
A guide to protocol development for low-income countries
Методы исследования в целях укрепления здоровья легких
Руководство по документированию развития для стран с низким уровнем дохо
...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Moz
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl
...
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....
This guide is an attempt to redress the deficit in understanding of implementation research and to encourage programme personnel and implementers to take a greater interest in the subject, recognizing that implementation
...
Western Pac Surveill Response J. 2014 Oct-Dec; 5(4): 34–46.
Published online 2014 Dec 18. doi: [10.5365/WPSAR.2014.5.4.007]
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire popu
...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.